Medicinal importance of grapefruit juice and its interaction with various drugs

被引:83
作者
Kiani, Jawad [1 ]
Imam, Sardar Z. [1 ]
机构
[1] Aga Khan Univ, Coll Med, Karachi, Pakistan
关键词
D O I
10.1186/1475-2891-6-33
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Grapefruit juice is consumed widely in today's health conscious world as a protector against cardiovascular diseases and cancers. It has however, been found to be an inhibitor of the intestinal cytochrome P - 450 3A4 system, which is responsible for the first pass metabolism of many drugs. The P - glycoprotein pump, found in the brush border of the intestinal wall which transports many of these cytochrome P - 450 3A4 substrates, has also been implicated to be inhibited by grapefruit juice. By inhibiting these enzyme systems, grapefruit juice alters the pharmacokinetics of a variety of medications, leading to elevation of their serum concentrations. Most notable are its effects on the calcium channel antagonist and the statin group of drugs. In the case of many drugs, the increased serum concentration has been found to be associated with increased frequency of dose dependent adverse effects. In this review, we have discussed the phytochemistry of grapefruit juice, the various drugs involved in the drug - grapefruit juice eraction with their mechanisms of action and have presented the clinical implications of these interactions.
引用
收藏
页数:9
相关论文
共 92 条
[1]   Intestinal first pass metabolism of midazolam in liver cirrhosis - effect of grapefruit juice [J].
Andersen, V ;
Pedersen, N ;
Larsen, NE ;
Sonne, J ;
Larsen, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (02) :120-124
[2]   Interactions between grapefruit juice and cardiovascular drugs [J].
Bailey D.G. ;
Dresser G.K. .
American Journal of Cardiovascular Drugs, 2004, 4 (5) :281-297
[3]   Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice [J].
Bailey, DG ;
Dresser, GK ;
Bend, JR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :529-537
[4]  
BAILEY DG, 1989, CLIN INVEST MED, V12, P357
[5]   GRAPEFRUIT JUICE FELODIPINE INTERACTION - MECHANISM, PREDICTABILITY, AND EFFECT OF NARINGIN [J].
BAILEY, DG ;
ARNOLD, JMO ;
MUNOZ, C ;
SPENCE, JD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) :637-642
[6]   EFFECT OF GRAPEFRUIT JUICE AND NARINGIN ON NISOLDIPINE PHARMACOKINETICS [J].
BAILEY, DG ;
ARNOLD, JMO ;
STRONG, HA ;
MUNOZ, C ;
SPENCE, JD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (06) :589-594
[7]   Grapefruit juice felodipine interaction:: Effect of naringin and 6′,7′-dihydroxybergamottin in humans [J].
Bailey, DG ;
Kreeft, JH ;
Munoz, C ;
Freeman, DJ ;
Bend, JR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (03) :248-256
[8]   INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE [J].
BAILEY, DG ;
SPENCE, JD ;
MUNOZ, C ;
ARNOLD, JMO .
LANCET, 1991, 337 (8736) :268-269
[9]   Grapefruit juice-drug interactions [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110
[10]   Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients [J].
Bailey, DG ;
Dresser, GR ;
Kreeft, JH ;
Munoz, C ;
Freeman, DJ ;
Bend, JR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) :468-477